UPDATE: Citi Upgrades Eli Lilly (LLY) to Buy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/1/2026

1. SPY
2. MDT
3. AON
4. ENOV
5. AZN
6. BLSM
7. KRMN
8. GRMN
9. GPRO
10. VRSK

April 29, 2015 6:52 AM EDT
Get Alerts LLY Hot Sheet
Price: $1,171.00 +1.23%

Rating Summary:
    30 Buy, 5 Hold, 3 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 10 | Down: 6 | New: 33
Join SI Premium – FREE
(Updated - April 29, 2015 9:58 AM EDT)

Citi upgraded Eli Lilly (NYSE: LLY) from Neutral to Buy with a price target of $100. Analysts raised evacetrapib risk peak sales estimates from $1 billion to $3.8 billion. The change follows Merck (NYSE: MRK) IMPROVE-IT data that showed its Vytorin validates cardio benefit of lowering LDL cholesterol with a non-statin agent.

For an analyst ratings summary and ratings history on Eli Lilly click here. For more ratings news on Eli Lilly click here.

Shares of Eli Lilly closed at $71.18 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Analyst EPS View, Hot Upgrades, Upgrades

Related Entities

Citi